期刊文献+

有机阴离子转运多肽1B1 521T〉C基因多态性与原发性高血压的相关性

The correlation between the OATP1B1 521T 〉 C genetic polymorphism and essential hypertension
原文传递
导出
摘要 目的探讨有机阴离子转运多肽181(OATP1B1)521T〉C与原发性高血压的相关性。方法采用实时荧光定量TaqMan—MGB探针法,检测164例原发性高血压患者和159例非高血压对照者OATP1B1521T〉C的基因型,并将其检测结果与DNA测序结果进行比较。结果高血压组OATP1BI521T〉c的T/C基因型频率明显低于对照组(16%、25%,P〈0.05),且OATP1B1521T〉C的c等位基因频率明显低于对照组(10%、17%,P〈0.05),而Logistic回归分析法对影响高血压的相关因素进行回归分析,亦显示OATP1B1521T〉C基因多态性与高血压有相关性(P〈0.05)。结论SLC01BI的521T〉C突变为中国原发性高血压人群中的常见突变,在原发性高血压人群和血压正常人群之间的分布有差异;SLC0181的52IT〉C突变与原发性高血压的发病之间可能具有相关性。 Objective To study the relationship between the OATP1B1 521T 〉 C genetic polymorphism and essential hypertension. Methods 164 essential hypertension subjects and 159 normotensive subjects were detected by the TaqMan-MGB probe real-time fluorescence quantitative PCR, and the results were compared with those of DNA sequencing. Results The frequencies of T/C genotype and C allele of OATP1B1 521T 〉 C gene of the essential hypertension subjects were obviously lower than those of the normotensive subjects(T/C genotype :0.16 vs 0.25 ,P 〈 0.05 ; C allele :0.10 vs 0.17 ,P 〈 0.05 ) ,The difference was significant. Binary logistic stepwise regression analysis was used for evaluatine the risk factors of essential hypertension, there was significant relationship between OATP1 B1 52IT 〉 C gene polymorphism and essential hypertension. Conclusion The SLCO1 B1 521T 〉 C variant was common in Chinese essential hypertension population,but the difference of frequency of SLCO1B1 521T 〉 C muton between the essential hypertension patients and the normotensive controls was of obviously statistical significance, which indicates that the SLCO1B1521T 〉 C variant maybe associate with essential hypertension,
出处 《中国基层医药》 CAS 2012年第5期646-648,共3页 Chinese Journal of Primary Medicine and Pharmacy
基金 基金项目:广东省科技计划项目(20098080701105)
关键词 OATP1B1 521T〉c 基因 多态性 原发性高血压 OATP1 B1 521T 〉 C Gene Polymorphism Essential Hypertension
  • 相关文献

参考文献1

二级参考文献21

  • 1Hagenbuch B, Meier PJ. The superfamily of organic anion transporting polypeptides. Biochim Biophys Acta 2003;1609(1):1-18. Review. 被引量:1
  • 2Kim RB. Organic anion-transporting polypeptide(OATP) transporter family and drug disposition. Eur J Clin Invest 2003; 33(Suppl 2): 1-5. 被引量:1
  • 3Abe T, Kakyo M, Tokui T, Nakagomi R, Nishio T, Nakai D, et al. Identification of a novel gene family encoding human liver-specific organic anion transporter LST-1. J Biol Chem 1999; 120: 17159-63. 被引量:1
  • 4Hsiang B, Zhu Y, Wang Z, Wu Y, Sasseville V, Yang WP, et al. A novel human hepatic organic anion transporting polypeptide 2(OATP2): identification of a liver-specific organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA-reductase inhibitor transporters. J Biol Chem 1999; 274: 37161-8. 被引量:1
  • 5Konig J, Cui Y, Nies AT, Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol Gastrointest Liver Physiol 2000; 278: G156-64. 被引量:1
  • 6Tirona RG, Leake BF, Merino G, Kim RB. Polymorphisms in OATP-C: identification of multiple allelic variants associated with altered transport activity among European and African-Americans. J Biol Chem 2001; 276: 35 669-75. 被引量:1
  • 7Nishizato Y, Ieiri I, Suzuki H, Kimura M, Kawabata K, Hirota T, et al. Polymorphisms of OATP-C(SLC21A6) and OAT3(SLC22A8) genes: consequences for pravastatin pharmaco-kinetics. Clin Pharmacol Ther 2003; 73: 554-65. 被引量:1
  • 8Mwinyi J, Johne A, Bauer S, Roots I, Gerloff T. Evidence for inverse effects of OATP-C(SLC21A6) *5 and *1b haplotypes on pravastatin kinetics. Clin Pharmacol Ther 2004; 75: 415-21. 被引量:1
  • 9Niemi M, Schaeffeler E, Langb T, Fromma MF, Neuvonen M, Kyrklund C, et al. High plasma pravastatin concentrations are associated with single nucleotide polymorphisms and haplotypes of organic anion transporting polypeptide-C(OATP-C, SLCO1B1). Pharmacogenetics 2004, 14: 429-40. 被引量:1
  • 10Kameyama Y, Yamashita K, Kobayash K, Hosokawa M, Chiba K. Functional characterization of SLCO1B1(OATP-C) variants, SLCO1B1*5, SLCO1B1*15 and SLCO1B1*15+C1007G, by using transient expression systems of HeLa and HEK293 cells. Pharmacogenet Genomics 2005; 15: 513-22. 被引量:1

共引文献17

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部